Table 2 Cytokine profile of various groups.
From: Activated T cell therapy targeting glioblastoma cancer stem cells
T0 | TNPP12 | TPP12 | |||||||
---|---|---|---|---|---|---|---|---|---|
Untreated | PP | T2-PP | Untreated | PP | T2-PP | Untreated | PP | T2-PP | |
% CD4+ IFN-γ | 0.0032 | 0.0075 | 0.029 | 0.61 | 0.52 | 1.04 | 0.41 | 2.17 | 2.58 |
% CD4+ DP | 0.0032 | 0.0075 | 0.012 | 0.013 | 0.013 | 0.042 | 0.02 | 0.58 | 0.31 |
% CD8+ IFN-γ | 0.0052 | 0.009 | 0.39 | 0.53 | 0.45 | 1.41 | 0.52 | 3.48 | 5.59 |
% CD8+ DP | 0.00 | 0.00 | 0.088 | 0.0056 | 0.0058 | 0.046 | 0.00 | 0.39 | 1.36 |
Total % IFN-γ | 0.0084 | 0.016 | 0.42 | 1.14 | 0.97 | 2.45 | 0.93 | 5.65 | 8.17 |